BVF INC/IL - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 81 filers reported holding IMMUNE DESIGN CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$6,741,000
-58.1%
5,185,383
+11.3%
0.88%
-37.6%
Q3 2018$16,071,000
-15.1%
4,658,353
+12.0%
1.41%
-23.6%
Q2 2018$18,921,000
+39.6%
4,158,353
+1.3%
1.85%
+34.4%
Q1 2018$13,550,000
+136.4%
4,106,200
+179.4%
1.37%
+98.8%
Q4 2017$5,732,000
-31.7%
1,469,800
+19.1%
0.69%
-51.6%
Q1 2017$8,391,000
+15.6%
1,233,976
-6.5%
1.43%
-2.2%
Q4 2016$7,261,000
-20.2%
1,320,164
+10.0%
1.46%
-14.9%
Q3 2016$9,096,0001,200,0001.71%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$3,532,0000.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 140,720$2,485,0000.10%
SECTORAL ASSET MANAGEMENT INC 95,000$1,678,0000.07%
Spark Investment Management LLC 18,900$329,0000.05%
Alyeska Investment Group, L.P. 46,833$827,0000.02%
FRANKLIN RESOURCES INC 802,000$14,163,0000.01%
Focused Wealth Management, Inc 450$8,0000.01%
PRICE T ROWE ASSOCIATES INC /MD/ 740,241$13,073,0000.00%
FMR LLC 900,000$15,894,0000.00%
BlackRock Fund Advisors 149,938$2,648,0000.00%
View complete list of IMMUNE DESIGN CORP shareholders